Press releases appear below, filter by date.
Comments are invited on proposals to amend Clause 16.3 with regards to representatives examinations.
Allergan Limited, Shire Pharmaceuticals Limited, Gedeon Richter and Sanofi have breached the ABPI Code of Practice for the Pharmaceutical Industry.
2014 Interactive Code launched. Updated guidance and advice documents published. Transfer of Value Disclosure Crib Notes published
Lundbeck Limited, A Menarini Pharma, Bayer plc, HRA Pharma UK and GlaxoSmithKline have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press.
Pharmaxis Pharmaceuticals Ltd has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.
The consultation has now closed.
Consultation launched on proposed changes to the ABPI Code of Practice for the Pharmaceutical Industry and the Constitution and Procedure for the Prescription Medicines Code of Practice Authority
The Prescription Medicines Code of Practice Authority (PMCPA) announced today that it will be working in partnership with The EarthWorks to create a communications programme, including an app to help increase understanding of the Code.
The PMCPA e-learning module for health professionals has been updated to reflect the 2014 Code of Practice.
Servier Laboratories Ltd has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.
Proposals to amend the Code agreed at ABPI General Meeting on 20 November.Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure were agreed at the Half Yearly General Meeting of the ABPI on 20 November 2014.
Galderma UK Ltd and Merck Serono have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press.
Chiesi has been publicly reprimanded for providing inaccurate information to the PMCPA during the course of a complaint about a leave piece and again during the course of a subsequent audit and is the subject of advertisements in the medical, pharmaceutical and nursing press.
